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Abstract
Background: Post-operative pulmonary complications are a significant problem following open upper abdominal
surgery. Preliminary evidence suggests that a single pre-operative physiotherapy education and preparatory lung
expansion training session alone may prevent respiratory complications more effectively than supervised post-
operative breathing and coughing exercises. However, the evidence is inconclusive due to methodological
limitations. No well-designed, adequately powered, randomised controlled trial has investigated the effect of pre-
operative education and training on post-operative respiratory complications, hospital length of stay, and health-
related quality of life following upper abdominal surgery.
Methods/design: The Lung Infection Prevention Post Surgery - Major Abdominal- with Pre-Operative Physiotherapy
(LIPPSMAck POP) trial is a pragmatic, investigator-initiated, bi-national, multi-centre, patient- and assessor-blinded,
parallel group, randomised controlled trial, powered for superiority. Four hundred and forty-one patients scheduled for
elective open upper abdominal surgery at two Australian and one New Zealand hospital will be randomised using
concealed allocation to receive either i) an information booklet or ii) an information booklet, plus one additional
pre-operative physiotherapy education and training session. The primary outcome is respiratory complication incidence
using standardised diagnostic criteria. Secondary outcomes include hospital length of stay and costs, pneumonia
diagnosis, intensive care unit readmission and length of stay, days/h to mobilise >1 min and >10 min, and, at 6 weeks
post-surgery, patient reported complications, health-related quality of life, and physical capacity.
Discussion: The LIPPSMAck POP trial is a multi-centre randomised controlled trial powered and designed to investigate
whether a single pre-operative physiotherapy session prevents post-operative respiratory complications. This trial
standardises post-operative assisted ambulation and physiotherapy, measures many known confounders, and includes
a post-discharge follow-up of complication rates, functional capacity, and health-related quality of life. This trial is
currently recruiting.
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Background
Elective upper abdominal surgery (UAS) is planned sur-
gery involving an open incision above or extending above
the umbilicus [1] and is predominately performed to
remove cancerous tissue. Approximately 500 to 1000 pro-
cedures per 100,000 head of population are performed
annually in developed countries [2, 3]. The most common
complication following UAS is a post-operative pulmonary
complication (PPC) [4] with a reported incidence of
13–53 % [5–10]. This is higher than the incidence for
other major surgical procedures such as open lung resec-
tion, cardiac surgery via sternotomy, open lower abdom-
inal surgery, and orthopaedic surgery [11–13]. A PPC is
either a specific respiratory complication such as pneu-
monia or an undefined respiratory dysfunction that is
clinically significant, compromises a patient’s predicted re-
covery, and requires additional medical management [14].
The variability in PPC rates following UAS may be
explained by the differing studied patient risk profiles and
PPC definitions utilised.
Respiratory pathophysiological changes after UAS are
well reported, including atelectasis, impaired mucociliary
clearance, diaphragm dysfunction, reduced lung volumes,
and respiratory muscle and cough strength deficiencies
[15–28]. These can contribute to bacterial proliferation
and/or severe atelectasis [17, 29], thus increasing res-
piratory infection risk [14, 15]. PPCs are associated with
increased morbidity, mortality, hospital expenditure, and
length of stay (LOS) [5, 30–32]. Strategies to prevent PPCs
should remain a high priority [33] due to their relatively
high prevalence, relationship to poor patient outcomes,
and increased health care costs.
Preventative non-pharmaceutical therapies such as coa-
ched deep breathing and coughing (DB&C) exercises and
early ambulation are traditionally provided to patients fol-
lowing UAS [34]. Additionally, incentive spirometers [35],
positive expiratory pressure (PEP) devices [36], and non-
invasive ventilation (NIV) [37] can be utilised. These are
often delivered by physiotherapists [8, 38], though in
countries where physiotherapists are not involved with
this patient group, this type of respiratory therapy is
provided by nurses, doctors, or other health professionals
[36, 39]. However, the efficacy of post-operative respira-
tory therapy to prevent PPCs following UAS is controver-
sial. Systematic reviews and meta-analyses have concluded
that lung expansion exercises including DB&C [40],
incentive spirometry [35], and PEP [41] are of little benefit
in reducing PPCs, with only NIV considered efficacious
[37, 42]. Specifically, when post-operative ambulation is
standardised, the addition of DB&C exercises does not re-
duce the incidence of PPCs in addition to assisted early
ambulation alone [7, 10]. However, almost all clinical trials
have included pre-operative physiotherapy (Pre-Op) edu-
cation and training as usual care delivery to all partici-
pants. It is possible that this intervention alone may have
independently reduced the risk of a PPC.
Evidence from six clinical trials [43–48] suggests that a
single Pre-Op education session may reduce PPC rates
by up to 78 % [47, 48] after UAS. However, these trials
have methodological limitations, including small sample
sizes, inconsistent end points, generalisability restrictions
(single-centre trials, predominantly low-risk patient
groups), sources of bias (non-random sampling, unblinded
assessors and Hawthorne effects), and non-standardisation
or reporting of potential confounders. These methodo-
logical limitations bring the reported effect on PPC rates
with pre-operative physiotherapy education into question.
Even if the reported benefit on PPC rates is a true effect,
it is not known if Pre-Op education and training would be
effective in the context of recent advances in perioperative
management such as Enhanced Recovery After Surgery
(ERAS) guidelines. This multimodal package of 10–18
care elements provides significant improvements in com-
plication rates and LOS [49]. Pre-operative education and
lung expansion training are strongly recommended within
ERAS guidelines, although it is acknowledged that evi-
dence to support this specific element is weak [50]. Add-
itionally, Pre-Op physiotherapy interventions previously
studied were predominantly provided the day before sur-
gery. This may not reflect current practice where, in many
centres, patients attend a multi-disciplinary assessment
clinic one to 6 weeks before their operation [51–53]. It is
unknown whether Pre-Op physiotherapy education pro-
vided at these longer time intervals might also produce
the previously reported effect on PPC prophylaxis.
Surveys of physiotherapy services to UAS patients in
Australia have shown a stark reduction in hospitals
(20 % down to 5 %) providing Pre-Op physiotherapy
over the past 15 years [34, 54]. The reasons for this
disinvestment of services are unknown. There are no cost-
benefit analysis studies investigating physiotherapy to re-
duce respiratory complications, so conclusive evidence to
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inform the allocation of physiotherapy services to pre-
operative education and training is lacking. Additionally,
only short-term outcomes have been assessed. Reducing
PPCs during the acute hospital stay may also improve
important patient-focused longer term outcomes such as
health-related quality of life (HRQoL) and physical cap-
acity following discharge.
Considering the relative high incidence of PPCs
following major UAS and the benefit to both the patient
and the health care system if these were reduced, a
well-designed, adequately powered trial is needed to
determine both the clinical effect and cost benefit that
Pre-Op physiotherapy education and training may, or may
not, have on reducing PPC incidence following major
UAS. Results will guide future cost-effective allocation of
services to patients who require UAS.
Trial objectives
The primary objective of the Lung Infection Prevention
Post Surgery - Major Abdominal - with Pre-Operative
Physiotherapy (LIPPSMAck POP) trial is to estimate the
effect that Pre-Op physiotherapy education and training
has on the incidence of PPCs following major UAS,
when compared to an information booklet alone.
Secondary objectives are to evaluate the effect of Pre-Op
physiotherapy on hospital and ICU LOS, hospital costs,
incidence of pneumonia, unplanned ICU admissions, time
to early ambulation, readiness to discharge from hospital,
and, at six weeks following surgery, patient-reported com-
plications, HRQoL, and functional capacity.
Methods/design
Trial design
The LIPPSMAck POP trial is a pragmatic, investigator-
initiated, bi-national, multi-centre, randomised controlled,
parallel group, clinical trial. It is patient- and assessor-
blinded, and powered for superiority. Eligible patients will
be randomly assigned via concealed allocation to receive
1) a pre-operative assessment by a physiotherapist and
provision of an information booklet (control) or 2) a pre-
operative assessment, information booklet, plus an
additional education and DB&C training session by a
physiotherapist (intervention). Post-operative respiratory
physiotherapy and assisted early mobilisation will be stan-
dardised for both groups. See Fig. 1 for a CONSORT dia-
gram of the LIPPSMAck POP trial and Table 1 for an
overview of the trial methods and design.
Trial setting
The three participating centres: the Launceston General
Hospital (Launceston, Tasmania, Australia), North Shore
Hospital (Auckland, New Zealand), and North West
Regional Hospital (Burnie, Tasmania, Australia), repre-
sent a range of public hospital types. The North West
Regional Hospital is a 240-bed rural secondary referral
hospital; the Launceston General Hospital is a 330-bed
inner-regional, primary referral hospital; and the North
Shore Hospital is a 600-bed metropolitan, primary refer-
ral hospital. North Shore Hospital has also implemented
Enhanced Recovery After Surgery (ERAS) guidelines to
all surgical units. All hospitals are government funded,
university affiliated, teaching hospitals.
Patients undergoing elective UAS at the participating
centres attend an outpatient Pre-Admission Clinic (PAC)
session one to six weeks prior to their operation where
they are assessed by a multi-disciplinary team consisting
of, as a minimum, a registered nurse, anaesthetist, and
doctor from the admitting surgical team. Information
about the surgical process, pain management, post-
operative drips and drains, and expected recovery process
are provided as standard care. Whereas, Pre-Op physio-
therapy education and training at PAC is not normally
provided, post-operative respiratory therapy and assisted
ambulation by a physiotherapist are provided as standard
care at the participating centres.
Each participating hospital’s institutional review board
has approved the trial (the Human Research Ethics
Committee (Tasmania) Network, Tasmania, Australia
(protocol reference: H0011911), the Health and Disability
Ethics Committee, New Zealand (protocol reference:
14/NTA/233)). The trial is conducted in accordance with
the Declaration of Helsinki and was prospectively
registered on 19 June 2013 at the Australian New Zealand
Clinical Trials Registry (http://www.anzctr.org.au):
ACTRN12613000664741.
Eligibility and exclusion criteria
Eligible participants are patients over the age of 18 years
attending PAC at the participating centres who are
scheduled for UAS expecting to require an abdominal
incision longer than 5 cm that will be above, or extend-
ing above, the umbilicus (Table 2) and requiring a mini-
mum overnight hospital stay.
Patients are excluded for any of the following criteria:
(i) unable to understand verbal instructions in English;
(ii) unable to participate in a single pre-admission
session with a physiotherapist; (iii) requiring emergency
surgery; (iv) a current hospital patient for a separate
episode of care; (v) requiring organ transplant; (vi) open
abdominal hernia repairs (hernia repairs are generally
low-risk procedures which frequently do not involve
extensive visceral manipulation and have fewer compli-
cations [55]); (vii) being unable to stand upright and am-
bulate for a maximum of 1 min.
Randomisation and allocation
An administration assistant independent to the trial will
prepare 441 sequentially numbered (1 to 441) opaque
envelopes each containing an allocation card wrapped in
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extra paper or aluminium foil [56]. Allocation sequence
is determined by a web-based computer generated
(http://www.randomizer.org/) blocked random number
table (7 blocks of 63; 1 = intervention, 2 = control). The
randomisation tables are then sealed in an opaque enve-
lope, locked within the research institute, and made un-
available to trial personnel. The number of consecutively
numbered envelopes provided to each site will be
dependent on funding agreements (that is, funded to
recruit one block of 63 participants or, on a per patient
recruit basis, until the end of the trial).
Local investigators will screen elective surgery and
PAC lists daily for eligible patients who will be met face
to face by local investigators at their PAC appointment.
Informed consent will be obtained from potential partic-
ipants; each eligible participant will be provided with a
trial information sheet which is explained verbally to
them and will be invited to participate. Those agreeing
will sign a consent form as required by local ethics
committees and in accordance with the Declaration of
Helsinki. Where the local investigator or eligible patient
is unable to attend PAC, the latter will be contacted by
Fig. 1 CONSORT flow diagram of the LIPPSMAck POP clinical trial. DB&C deep breathing and coughing, PPC post-operative pulmonary complications,
HRQOL health-related quality of life
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Table 1 World Health Organisation (WHO) Trial Registration Data Set for LIPPSMAck POP trial
Data category Information
Primary registry and trial identifying number Australian New Zealand Clinical Trials Registry number: ACTRN12613000664741
Date of registration in primary registry 19/6/2013
Secondary identifying numbers n/a
Trial protocol version This is Version 4 of the protocol and was enacted on June 2013
Source(s) of monetary or material support Clifford Craig Medical Research Trust ($60,000 AUD)
University of Tasmania, virtual Tasmanian Academic Health Precinct ($50,000 AUD)
Waitemata District Health Board and Three Harbours Health Foundation ($20,000 NZD)
Tasmanian Health Service - Northern Region ($120,000 AUD)
Primary sponsor Tasmanian Health Service - Northern Region
Secondary sponsor Waitemata District Health Board
Contact for public queries IB, ianthe.boden@ths.tas.gov.au
Contact for scientific queries IB, ianthe.boden@ths.tas.gov.au
Public title Pre-operative physiotherapy education for the prevention of chest infections following major
abdominal surgery
Scientific title LIPPSMAck POP trial – Pre-operative physiotherapy education for the prevention of post-operative
pulmonary complications following major upper abdominal surgery: a bi-national, multi-centre,
randomised, double-blinded placebo controlled trial.
Countries of recruitment Australia, New Zealand
Health condition(s) or problem(s) studied Pulmonary complications following major upper abdominal surgery
Intervention(s) Active comparator: Pre-operative physiotherapy education and training
Placebo comparator: Education booklet
Key inclusion and exclusion criteria Ages eligible for study: ≥ 18 years
Sexes eligible for study: both
Accepts health volunteers: No
Inclusion criteria: All adults awaiting elective upper abdominal surgery involving an open incision
above the umbilicus.
Exclusion criteria: 1. Any pre-existing condition that would limit ability to participate in the standardised
post-operative mobilisation protocol. Defined as any person unable to stand upright and walk for a
maximum of 1 min without a seated rest. 2. Unable to understand verbal instructions in English. 3.
Unable to attend a pre-admission assessment and education session with a physiotherapist. 4. Open
abdominal hernia repairs.
Study type Type: Investigator initiated, interventional, non-pharmacological, pragmatic, study
Allocation: Concealed randomisation
Intervention model: parallel assignment
Masking: patient and assessor blinded
Primary purpose: Prevention
Phase: Phase III
Date of first enrolment 24/6/2013
Target sample size 441
Recruitment status Recruiting
Primary outcome(s) Post-operative pulmonary complications during the first 14 days of the hospital stay
Key secondary outcomes Pneumonia, length of hospital stay, hospital costs, day of ambulation >10mins, length of ICU stay,
ICU readmission, post-operative adverse events, day to discharge from post-operative physiotherapy
services, patient-reported complications, health-related quality of life, and physical capacity at
6 weeks following discharge from hospital.
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telephone and invited to enter the trial. The information
and consent form will be mailed by post for signing, and
the participant will be requested to bring them to hos-
pital on the day of their operation.
Once informed consent has been obtained and the
consent form signed, the pre-operative physiotherapist
receives the group allocation for participants by opening
the next sequentially numbered sealed opaque envelope
containing the randomised group allocation. Patient de-
tails will be written on the envelope once opened to en-
sure that patients are randomised in the same order as
recruited and the envelopes filed securely along with the
consent form. Potential selection bias will be studied by
extracting basic demographic data and planned surgical
procedure from all excluded patients’ medical records.
Trial interventions
Consenting participants will be randomly assigned to re-
ceive either i) a pre-operative assessment from a phy-
siotherapist and provision of an information booklet
(control) or ii) an additional education and DB&C train-
ing session (intervention).
Control group
Participants will have a standardised assessment con-
ducted by a physiotherapist consisting of: questioning on
current health co-morbidities, mobility and functional sta-
tus, smoking history, lung auscultation, subjective assess-
ment of cough quality and strength, sputum production
and colour, hand grip strength, Rapid Assessment of
Physical Activity (RAPA) [57] and Specific Activity
Questionnaire (SAQ) [58] to determine current activity
and fitness levels, and Short Form 36 (SF-36 V2) [59] to
measure HRQoL (see Data Collection section for further
details). Participants will then be provided with an educa-
tion booklet. This colour booklet contains written and
pictorial information about abdominal surgery, expected
types of pain management, medical lines and drains, post-
operative recovery process, and how to prevent post-
operative respiratory complications with early ambulation
and self-directed DB&C exercises. The booklet includes
detailed written instructions to perform DB&C exercises
for two sets of 10 deep breaths followed by three coughs
every hour during waking hours. Participants will be
instructed to bring the booklet to hospital for reference
following the operation. The contents of the booklet will
not be discussed with participants in the control group
and there will be no additional physiotherapy provided
pre-operatively.
Intervention group
Intervention group participants will be assessed and pro-
vided with an information booklet as per the control
group and will then receive an additional single educa-
tion and training session of approximately 30 min with a
physiotherapist. Participants will be given an estimate of
their likelihood of a PPC based on a risk prediction tool
[5] and educated about the effect of anaesthesia, UAS,
and bed rest on mucociliary clearance and lung volumes
[19, 20]. To ameliorate these factors and prevent bacteria
stagnation [15, 16] the importance of participating in an
early post-operative ambulation program and performing
self-directed DB&C exercises will be emphasised. Partici-
pants will be informed that a physiotherapist will assist
them to walk as soon as possible on the first post-
operative day, aiming for a duration longer than 10 min
and at a pace causing mild breathlessness. Outside these
assisted sessions, participants will be advised to walk or
exercise by their bedside as frequently as they are able.
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As it is frequently not possible to ambulate as early
and as often as recommended to assist in preventing
respiratory complications [8, 60], participants will be
educated on the necessity of performing self-directed
breathing exercises to protect their lungs following their
operation. They will be instructed to perform DB&C ex-
ercises immediately from waking from the anaesthetic
and then every hour during daytime waking hours until
their first ambulation session, and then at any time when
they are not ambulant. The physiotherapist will coach
each participant in at least three repetitions, and as
many as required to master technique as judged by the
physiotherapist. This trial’s DB&C exercises consist of
two sets of 10 slow-flow breaths to maximum inspira-
tory capacity with two to three inspiratory sniff breath
stacking manoeuvres [61]. Each breath is held for 3 to 5
s. Each set of 10 breaths is followed by three coughs, or
a forced expiratory technique with an open glottis called
a ‘huff ’, with a small firm pillow pressed over on the ab-
dominal incision to support the wound and to encourage
greater expiratory force. Participants will be encouraged
to practice these exercises prior to their operation to de-
velop familiarity.
Standardisation of pre-operative interventions
The information booklet content will remain consistent
between participating centres, although the formatting
may change for site-specific requirements. All participat-
ing pre-operative physiotherapists will be required to
view a scripted audio-visual recording of the pre-
operative intervention prior to recruiting their first pa-
tient. They are instructed to adhere to the overall
themes and premises of information delivery as included
within the protocol script and video. Years of experience,
seniority grade, and numbers of participants seen by
each physiotherapist will be reported.
Ideally, interventions will be provided in person at
PAC within six weeks of the scheduled surgery. How-
ever, in keeping with a pragmatic approach, if an
eligible patient or physiotherapist is unable to attend
PAC, patients can be enrolled, randomised, and pro-
vided with the interventions on another convenient
day, or via telephone, prior to surgery. The mode of
delivery will be recorded and the total proportion of
telephone sessions will be reported. If a participant’s
operation is delayed and the time from Pre-Op physio-
therapy to day of surgery becomes greater than 42 days,
a physiotherapist will contact the participant by phone
for a review assessment and to remind them to read the
booklet as provided at PAC. Participants allocated to
the intervention group will, in addition, have a review
of the education session and the DB&C exercises re-
peated over the phone.
Standardisation of post-operative procedures
At the first available opportunity following surgery, all
participants will be seen by a physiotherapist for a
standardised assisted ambulation session (see Table 3).
Ambulation is defined as marching on the spot beside
the bed or walking away from the bedside for more than
1 min. Once a patient is ambulant for more than one
minute, an Allied Health Assistant (AHA) will conduct
all further ambulation sessions. If an AHA is unavailable,
then a physiotherapist will continue to provide assisted
ambulation. Health professionals (profession and years
of experience) delivering ambulation will be reported.
Participants will be seen once daily until discharged
from physiotherapy services using defined scoring cri-
teria [62] (see Table 4) or until discharged from hospital.
At each session the participant will be progressed
sequentially through the ambulation protocol stages
aiming to achieve a walking time of more than 10 min at
an intensity of at least three on the Borg 10-point visual
analogue scale of perceived exertion [63] and where
breathing is deeper than at rest. If necessary, ambulation
sessions can comprise intervals at a work/rest ratio of
1:1. Shorter, but not longer, rest times are allowable. The
final achieved ambulation stage is the total amount of
time walked, not including rest periods. If participants
are unavailable or unable to achieve ambulation for
more than 1 min, the assisted ambulation session will be
attempted again later in the day. Reasons will be re-
corded where participants are unable to ambulate or do
not achieve a minimum of 10 min walking. Physiothera-
pists and AHAs will be provided with protocol prompt
cards and trained by the site investigator.
At the first ambulation session participants will be
provided with a walking aid if required, an abdominal
support pillow for use during coughing, and a brief re-
minder to perform DB&C exercises as described within
the information booklet provide pre-operatively. If a par-
ticipant has forgotten his/her booklet, a new one will be
provided. Participants will be encouraged to ambulate
frequently to aid in the prevention of PPCs and encour-
aged to seek assistance from a nurse if necessary and to
Table 3 LIPPSMAck POP ambulation protocol
Stage 1 (Safety) Sit over edge of bed/sit in chair
minimum of 2 min
Stage 2 (Safety) March on spot 0–1 min
Stage 3 (Ambulation) March on spot/walk away from
bedside 1–3 min
Stage 4 (Ambulation) March on spot/walk away from
bedside 3–6 min
Stage 5 (Ambulation) Walk away from bedside 6–10 min
Stage 6 (Ambulation) Walk away from bedside 10–15 min
Stage 7 (Ambulation) Walk away from bedside >15 min
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walk with their visitors. There will be no further
provision of DB&C, PEP devices, incentive spirometers,
or NIV by physiotherapists or AHAs.
Additional ambulation occasions outside physio-
therapy assisted sessions or other ward staff encouraging
patients to perform respiratory exercises will not be
measured or controlled, as this would not be feasible.
Both are considered standard ward care for both control
and intervention group participants. However, if a
participant is provided with an incentive spirometer or
PEP device, this will be immediately removed. The break
to protocol and duration of access to device will be
recorded.
All other aspects of patient care, including pre-
operative preparation, general anaesthesia, intraoperative
ventilation parameters, fluid delivery, prophylactic anti-
biotic prescription, pain management, use of lines and
drains, general nursing care, and discharge planning, will
be provided at the discretion of nurses and physicians
according to routine clinical practice at each participat-
ing centre.
Blinding
Pre-admission clinic nurses and physiotherapists aware of
group allocation will not have contact with participants
post-operatively. A trial participation sticker (excluding
group allocation) will be placed in the medical record. All
post-operative ward staff, physiotherapists, PPC assessors,
doctors, surgeons, nurses, discharge planners, data ana-
lysts, and statisticians will be blinded to group allocation.
If a treatment group participant informs the assessor of
their pre-operative education session, this will be noted
and reported.
It is anticipated that patients will consider the pre-
operative physiotherapy assessment and provision of a
booklet an acceptable ‘sham’ treatment. This will be
measured by interviewing a convenience sample of 30
consecutive participants via a semi-structured interview
on their fifth post-operative day, or on the day of dis-
charge, whichever comes first. They will be asked which
group they believed they had been allocated to and, to
test fidelity of the intervention over the control, what
they remembered from their pre-operative physiotherapy
session. The success of participant and therapist blinding
will be tested and reported by requiring post-operative
physiotherapists, AHAs, and assessors to guess group
allocation for each of these 30 participants.
Withdrawal from trial
Participants will be withdrawn for either of the follow-
ing: (i) failure to progress to surgery within the first 3
months of PAC attendance or (ii) withdrawal of consent.
All withdrawals and reasons will be reported.
Primary outcome
The primary outcome is the development of a PPC
within the first 14 post-operative hospital days. PPCs will
be diagnosed with the Melbourne Group Scale (MGS)
diagnostic scoring tool, which is reliable and valid fol-
lowing UAS and thoracic surgery [5, 8] and has high
inter-rater reliability [64]. This tool has eight clinical
criteria: four factors relating to symptoms and four to
diagnostic markers (Table 5). A PPC will be diagnosed
when four or more factors are present from midnight to
midnight on one post-operative day.
Participants will be assessed prospectively and daily
for a PPC by a blinded assessor until the seventh post-
operative day. Thereafter, additional PPC assessments
are performed only as clinically suspected until day 14
when there are signs or symptoms of respiratory system
deterioration reported within the medical record. To re-
duce the potential for missing data, retrospective collec-
tion of PPC data from the daily medical record will be
permitted when a patient or assessor is unavailable for
PPC assessment. The proportion of retrospective assess-
ments will be reported. Components will be collected
via the patient’s medical record and pathology/radiology
databases. Diagnostic components (chest X-ray (CXR),
white cell count (WCC), sputum microbiology) are
Table 4 Discharge from physiotherapy scoring tool [62]
Mobility Score
Reached pre-operative ambulation status 3
Requires supervision, status has plateaued 2
Requires assistance, status is improving 1
Unable to ambulate 0
Breath sounds
Reached pre-operative levels and within expectations for
that patient
3
Slightly decreased breath sounds or presence of a few
added sounds
2




Able to clear secretions independently OR at pre-operative status 3
Requires assistance to clear secretions 1
SpO2% (on room air or pre-op oxygen levels)
SpO2 ≥ 92 % (no respiratory condition) OR SpO2 ≥ 88 %
(existing respiratory condition)
3
SpO2 < 92 % (no respiratory condition) OR SpO2 < 88 %
(existing respiratory condition)
2
Respiratory rate (at rest and during activity)
Within normal expectations 3
Outside acceptable range for the individual 2
Total score (min 6, max 15)
A score ≥14 = discharge from physiotherapy
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recorded only if results are available. All medical officers
are masked to group allocation and these diagnostic
tests are ordered only as clinically indicated, and not
routinely for the purposes of the LIPPSMAck POP trial.
For this trial, modifications (* in Table 5) have been
made to diagnostic criteria to ensure that respiratory
therapy will not be withheld longer than necessary from
patients who may have developed a PPC. A CXR can be
verbally reported by a blinded senior respiratory physio-
therapist or ward physician, rather than awaiting a radi-
ologist report. When three factors (out of a possible
eight) in the MGS PPC tool are present, the blinded as-
sessor or ward physiotherapist will contact the surgical
ward doctor and discuss the option of further diagnostic
testing to rule in or out a PPC. Additionally, these pa-
tients will be assessed twice daily to monitor clinical cri-
teria for any deterioration.
A positive diagnosis of a PPC will be confirmed by a
blinded senior physiotherapist, and the participant will
then receive respiratory treatment as determined by the
ward physiotherapist.
Secondary trial outcomes
Secondary outcomes (Fig. 2) are:
1) Days of hospital length of stay (LOS). This is defined
as the continuous time spent in any type of inpatient
hospital service (acute care, sub-acute rehabilitation,
and time at another hospital) from the day of
admission to the day of discharge to a community
dwelling
2) ICU LOS in days;
3) Unplanned ICU admission at any time point during
the acute stay;
4) Pneumonia, defined as the presence of new CXR
infiltrates along with at least two of the following
criteria: temperature >38 °C, dyspnoea, cough and
purulent sputum, altered respiratory auscultation,
and WCC >14,000/ml or leukopenia <3000/ml [65]
on any day within the first 14 post-operative
hospital days;
5) Time in hours from end of operation to time able
to achieve ambulation greater than 1 min;
6) Time in days from end of operation to
post-operative day able to achieve ambulation
greater than10 min;
7) Time in days to discharge from physiotherapy
service (Table 4) [62];
8) Time in days to readiness for discharge from
hospital as defined by standardised scoring
criteria [66];
9) Hospital costs for the UAS admission episode of
care. This will be supplied by the participating
centres’ or health departments’ costing data for
each participant’s admission episode.
10) Patient-reported complications at 6 to 8 weeks
following day of surgery using a standardised
semi-structured interview; and
11) HRQoL using the SF-36 and functional capacity
using SAQ [58, 67] at 6 to 8 weeks following day
of surgery.
Post-hospital discharge follow-up of self-reported
complications, SF-36, and functional capacity will be via
phone interview with a site investigator at 6 weeks from
the date of surgery. If patients are unable to be con-
tacted by phone for a period of five consecutive working
days, a standardised cover letter, questionnaires, and
self-addressed return paid envelope will be posted to the
participant. Forms not returned within 2 weeks of post-




To measure baseline characteristics the following variables
will be collected directly from the patient or the medical
record: centre of recruitment, age, gender, height (cm),
weight (kg), body mass index (kg/cm2), planned surgical
procedure, category (hepatobiliary/upper gastrointestinal,
colorectal, renal and urology, vascular, or other) and reason
for the procedure, physical health status according to the
American Society of Anaesthesiologists (ASA) and rated
by the attending anaesthetist at the PAC (score 1 to 5),
chemotherapy during the preceding 6 weeks, presence of
a nasogastric tube before operation, respiratory status
(auscultation signs and patient report of a daily productive
cough), cough strength and presence of sputum (patient is
Table 5 MGS PPC diagnostic criteria with modifications*
Diagnosis confirmed when four or more of the following are present:
Clinical factors
• New abnormal breath sounds on auscultation different to pre-operative
assessment
• Production of yellow or green sputum different to pre-operative
assessment
• Pulse oximetry oxygen saturation (SpO2) <90 % on room air on more
than one consecutive post-operative day
• Raised maximum oral temperature >38 °C more than one
consecutive day
Diagnostic factors
• Chest radiograph report of collapse/consolidation. *When a CXR has
been taken but no report is available, a ward medical officer or a
senior respiratory physiotherapist with more than 10 years’ experience
will be asked to report
• An unexplained WCC greater than 11 × 109/L
• Presence of infection on sputum culture report
• Physician’s diagnosis of *pneumonia, URTI, or an undefined chest
infection, or prescription of an antibiotic for a respiratory infection
* modification made to original criteria
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asked to cough forcibly, the physiotherapist makes a sub-
jective scoring of strength, effectiveness, and presence of
sputum), sputum class (mucoid, mucopurulent, purulent)
and colour using a validated colour chart tool [68] of any
observed or patient reported regularly produced bronchial
secretions, patient-reported history of a chest infection in
the previous 14 days and if antibiotics had been
prescribed, smoking history (non-smoker, current smoker,
or ex-smoker having ceased more than 8 weeks pre-
operatively), smoking pack years (1 pack year = 20 ciga-
rettes per day for 1 year), years since smoking cessation,
SpO2 (%) on room air, heart rate (beats per minute), co-
morbidities as documented in the medical record (history
of stroke or any other type of debilitating neurological
disease, diabetes, arthritis, osteoporosis, asthma, COPD or
other type of chronic respiratory disease, history of an
acute myocardial infarct or angina, peripheral vascular
disease, upper gastrointestinal disease such as reflux or
gastric ulceration, current depressive illness or anxiety/
panic disorder, visual or hearing impairment), patient’s self-
report if the listed comorbidities significantly limit their
walking on a day-to-day basis, Functional Comorbidity
Index score [69], HRQoL with the SF-36, patient-reported
estimated maximum metabolic equivalent (MET) physical
activity using a self-rated physical Specific Activity
Questionnaire (SAQ) [58], patient-reported measure of
physical activity status using the Rapid Assessment of
Physical Activity (RAPA) questionnaire and categorised
to sedentary, under active, under active regular light activ-
ities, under active regular, and active [57], patient-reported
maximum walking time along flat ground at comfortable
walking pace, any limiting factor for mobilisation, and
maximum grip strength as measured on the dominant
hand using a calibrated hand dynamometer (Jamar Plus+;
Sammons Preston, Rolyon, Bolingbrook, IL) performed
with patients seated with shoulders adducted, elbows
flexed to 90°, and forearms in the neutral position. The
dynamometer handle position will be set to the second
position for all tests [70], and three tests will be performed
with verbal encouragement with the best test result
recorded.
Intra-operative variables
The following variables will be collected from the
anaesthetic record, operation report, and medical record:
duration of anaesthesia during surgery in minutes;
mechanical ventilation parameters including mode of
ventilation, level of pressure/volume control, and PEEP;
average FiO2 during surgery; type and amount of intraop-
erative fluid delivered (ml/kg/h); numbers of blood
Fig. 2 LIPPSMAck POP participant timeline and schedule of events. Describes LIPPSMAck POP participant timeline and schedule of procedures.
Abbreviations: POD postoperative day, D/C discharge, DB&C deep breathing and coughing, RAPA Rapid Assessment of Physical Activity, PPC postoperative
pulmonary complication, ICU intensive care unit, LOS length of stay, HRQOL health-related quality of life, SAQ Specific Activity Questionnaire
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transfusion units; prophylactic antibiotic delivery (medica-
tion and dosage); incision type (midline, unilateral subcos-
tal, bilateral subcostal, transverse, combined thoracotomy,
other). If there are multiple incisions used, the patient’s
incision is categorised according to the closest abdominal
incision to the thorax.
Post-operative variables
Post-operative data will be collected daily for 14 days or
until discharge from hospital, whichever occurs first:
time in days from the pre-operative physiotherapy ses-
sion to the operation; PPC risk stratification (low or
high) using a defined risk calculation tool [5]; location
(ICU, surgical ward, other) and duration in days at each
location; days of analgesia and type (epidural, constant
opioid infusion, patient controlled analgesia (PCA), pa-
tient controlled epidural analgesia (PCEA), oral, local
pain infusion, or other); unplanned ICU/HDU admission
and length of total ICU/HDU stay; length in days of total
hospital stay; hours of mechanical ventilation; fluid de-
livery in the first 24 h (ml/kg/h); days and type of vaso-
pressor use; hours and type of NIV use; days and types
of oxygen therapy use; days, type, and indication for use
for antibiotics; days and types of all drains and lines; day
and diagnosis of a prolonged post-operative ileus using a
standardised criteria [71] of 2 or more of the following
factors in a 24-h period including nausea/vomiting, in-
ability to tolerate normal diet, absence of flatus, abdom-
inal distension, radiologic confirmation, and physician
diagnosis of ileus.
Early ambulation parameters will be collected, includ-
ing: time in hours from end of surgery until time to am-
bulation >1 min; post-operative day walked longer than
10 min; maximum rating of perceived exertion during
ambulation at each session; maximum ambulation stage
attained at each session (Table 2); number of assisted
ambulation occasions; reasons for a patient being unable
to participate in an ambulation session.
Sample size
Sample size was calculated using inference for propor-
tions comparing two independent samples with a 0.05
two-sided significance level and will have 80 % power to
detect a 10 % absolute difference in PPC between Pre-
Op (estimated at 10 %) and an education booklet
(estimated at 20 %) when the sample size is 398. This is
further increased by 11 % to account for attrition, result-
ing in a final sample size of 441.
Data management
Data will be collected from participants using a standar-
dised electronic case report form (CRF) and stored in
participating centres’ password protected electronic hard
drives. To ensure data quality the CRF has been
designed with extensive use of data entry limitation rules
and on-screen prompts to ensure correct data entry. Pri-
mary and secondary outcome data entry fields will be
highlighted and required for completion of each partici-
pant’s data set. Automated weekly prompts will remind
site investigators to complete any missing data points.
All site investigators will be trained directly by the prin-
cipal investigator on correct administration of the trial.
Site investigators will be required to perform random cov-
ert audits of data collected by trial personnel during the
trial for reliability and correctness against the medical rec-
ord. Once each participant’s data set is completed, it is de-
identified, entered into a central database, and maintained
securely by the principal investigator. All data, consent
forms, and relevant correspondence will be stored accord-
ing to Australian and New Zealand privacy laws and ar-
chived at trial sites for a minimum of 7 years. There are
no industrial contractual arrangements in relation to the
de-identified data. On completion of the trial, the database
will be made available for independent analysis or as an
appendix in the publishing journal if requested.
Statistical methods
The prognostic strength and size of imbalances to po-
tential confounding baseline variables between groups
will be assessed. Adjustment covariates will be selected
by backward stepwise regression from covariates that
may have the potential for clinically significant alter-
ations in effect sizes. These include: history of a respira-
tory comorbidity, smoking history, self-reported physical
activity levels, age, BMI, length in time of operation,
operation category (upper gastrointestinal, colorectal,
urological, other), ICU admission immediately following
the procedure, incision type and location [72], intra-
operative ventilation strategies [4, 73], fluid delivery [74],
blood transfusions [75], mode of post-operative analgesia
[76], and use of prophylactic antibiotics [50].
All outcomes are to be analysed using intention-to-treat.
The absolute and relative rates of PPC in the trial groups
will be estimated using multivariate robust random effects
Poisson generalised linear regression to allow assessment of
binary outcomes with or without adjustment for potential
confounding variables (incidence rates and rate ratios, 95 %
confidence intervals, P-values). Treatment centre will be
treated as a fixed variable in the multi-level models. In
addition, the effect of time from the end of surgery/anaes-
thesia to commencement of symptoms of PPC will be com-
pared using Cox proportional hazards regression with and
without covariate adjustment (hazards ratio, 95 % confi-
dence intervals, P-values). Graphic representation of this
analysis will be performed using the Kaplan-Meier method.
Binomial secondary outcomes, including pneumonia,
unplanned ICU admission, and patient reported com-
plications, will be analysed using mixed effects Poisson
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regression. Secondary outcomes with irregular distribu-
tions, including length of time periods (ICU and total
post-operative LOS, time to ambulation for 1 and 10 min,
and time to discharge from assisted ambulation physio-
therapy service), HRQoL, and functional capacity, will be
evaluated for group differences using mixed effects or-
dered logistic regression, with mean time (95 % CI) esti-
mated for descriptive purposes using mixed effects linear
regression, with or without log transformation depending
on distribution. Hospital costs associated with the inter-
ventions will be compared using mixed effects linear re-
gression. Log transformation of highly skewed cost data
will be performed.
An intention-to-protocol sensitivity analysis will be
performed by excluding from the analysis any partici-
pant who did not undergo the anticipated scheduled
upper abdominal surgery defined as a 5-cm incision or
longer above, or extending above, the umbilicus. For ex-
ample, this will include those participants who were
scheduled for open surgery yet went on to only have a
laparoscopic procedure or where the open incision
remained wholly below the umbilicus.
The sensitivity of the outcome estimates to missing data
will be evaluated using multiple imputation (Stata com-
mand syntax mi). All analyses will be performed using Stata
version 13 or later (StataCorp, College Station, TX, USA).
Data monitoring
The steering committee consists of the principal investi-
gator and three academic supervisors who contribute to
design and revision of the study protocol. The principal
investigator is responsible for study administrative man-
agement and communication with local investigators,
and for assisting participating centres with trial conduct,
record keeping, and data management. An independent
Data and Safety Monitoring Board (DSMB) consisting of
a senior academic, staff anaesthetist, and biostatistician
monitors the ethics of the study in accordance with the
Declaration of Helsinki, overseeing safety and conduct of
the study. This study compares two education-based
treatment strategies that are highly unlikely to be related
to serious adverse events (SAEs), though local investi-
gators at participating centres remain responsible for
reporting SAEs directly attributable to the intervention
or control to the DSMB for review and consideration for
referral to the institutional ethics review board.
Duration and timeline
All 441 patients will be recruited by October 2015. Data
collection will be completed, analysed, and the manu-
script prepared for submission by March 2016. The final
manuscript will be written in accordance with the
CONSORT extensions for a pragmatic trial using a non-
pharmacological intervention.
Discussion
Studies in major UAS that have used the same PPC diag-
nostic tool as our group have reported a PPC rate of
13–18 % across all types of UAS [5, 6] with a specific
rate of approximately 40 % in high-risk patients [8, 9].
Due to high incidence rates and costs of PPCs to pa-
tients and health care systems, there is great interest in
their prevention.
Several clinical trials have compared a variety of differ-
ent types and combinations of interventions to prevent
PPCs. Trials demonstrating improvements in PPC rates
have used multimodal interventions, so it is difficult to
determine which component is effective in reducing
PPCs, or indeed, if it is necessary to provide the whole
‘package of care’ to gain a significant benefit. This may
influence resource provision, as providing the full pack-
age of therapy exactly as studied to gain the reported re-
duction on PPC rates may not be feasible, could be
costly, and, indeed, may not be necessary in its entirety.
Previous clinical trials have demonstrated that a single
pre-operative education session can reduce PPC inci-
dence to as low as 6 %, compared to a no-treatment
control group rate of 27 %, P < 0.001 [47, 48], though as-
sessors were un-blinded and potential confounders were
not reported. Further, these trials were conducted 10–15
years ago, and changes in surgical and perioperative care
have been significant in this time. The potential to sig-
nificantly reduce the incidence of a high impact compli-
cation such as a post-operative respiratory complication
with a low-cost and easily provided intervention of a
single pre-operative physiotherapy session is appealing.
It may not be ‘how much’ physiotherapy that is import-
ant, but rather ‘when’ that physiotherapy is provided.
Unfortunately, conclusive evidence to support this
hypothesis is lacking.
The LIPPSMAck POP trial is the first randomised
controlled study powered and designed to investigate
whether Pre-Op education and training reduces the inci-
dence of PPCs. This RCT has been specifically designed
to address previous methodological shortcomings in
clinical trials investigating this intervention. Eligible par-
ticipants are all patients listed for elective upper abdom-
inal surgery and are representative of the heterogeneous
nature of patients listed for these procedures. To ensure
generalisability of results, the intervention will be deliv-
ered pragmatically and reflect current service delivery in
Australia and New Zealand. Pre-operative education will
be provided by a range of physiotherapists with different
experience levels, including supervised students. The
intervention and control has been designed and standar-
dised to be provided by a physiotherapist of any experi-
ence level.
The active control of being assessed by a physiotherapist
and receiving an identical subjective and objective
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interview and booklet, was chosen instead of a no-
treatment comparator to specifically control for the Haw-
thorne effect. The LIPPSMAck POP trial standardises
assisted early ambulation services and removes all
physiotherapy coached respiratory therapy and provision
of lung expansion devices post-operatively. We have not
attempted to control for ambulation initiated by the par-
ticipant or lung expansion exercises provided by nursing
or medical staff and, in practice, this would be extremely
difficult to achieve. However, with effective random allo-
cation and blinding of post-operative staff members, it is
reasonable to expect that patients in both the control
and the intervention group will have an equal chance of
having similar exposure to these factors. Regarding other
known confounders such as pain management strategies,
fluid administration, and intraoperative ventilation strat-
egies, we have not attempted to standardise these due to
the feasibility of doing so across three sites. Instead, the
impact of potential perioperative confounders will be
evaluated during statistical analysis and reported.
The primary outcome, PPC, will be measured by as-
sessors masked to group allocation; all post-operative
ward staff responsible for the delivery of all physiother-
apy, medical, nursing, and general care and discharge
planning will also be masked. The success of blinding
procedures will be measured and reported. In modern
health care delivery it is also important to consider the
impact of an intervention on patient reported quality of
life and not just on objective clinical outcomes [77]. It is
hypothesised that if Pre-Op physiotherapy education is
effective in reducing the incidence of a PPC, this may
improve post-surgical recovery. Improvements in re-
covery may influence HRQoL following discharge from
hospital, particularly physical functioning domains, as
has been demonstrated previously [59]. LIPPSMAck
POP will be measuring 6-week post-discharge patient re-
ported complications, HRQoL, and functional capacity
to estimate the potential effect that PPCs may have on
these outcomes.
In conclusion, the LIPPSMAck POP trial is an
investigator-initiated, bi-national, multi-centre, pragmatic,
double-blinded, randomised controlled trial, powered and
rigorously designed to test the hypothesis that pre-
operative physiotherapy education prevents post-operative
pulmonary complications in patients following major
upper abdominal surgery.
Trial status
The trial is ongoing and is actively enrolling.
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